Cleared Traditional

K170222 - Rapid Tox Cup II

K170222 is an FDA 510(k) clearance for Rapid Tox Cup II, manufactured by American Bio Medica Corp.. The device is a Class 2 Toxicology device with product code LAF cleared through the Traditional 510(k) pathway after a 202-day FDA review.

K170222 · American Bio Medica Corp. · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2017
Decision
202d
Days
Class 2
Risk

K170222 is an FDA 510(k) clearance for the Rapid Tox Cup II. Classified as Gas Chromatography, Methamphetamine (product code LAF), Class II - Special Controls.

Submitted by American Bio Medica Corp. (Kinderhook, US). The FDA issued a Cleared decision on August 15, 2017 after a review of 202 days - an extended review cycle.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3610 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Toxicology review framework, consistent with the majority of Class II 510(k) submissions.

View all American Bio Medica Corp. devices

FDA 510(k) Submission Details - K170222

510(k) Number K170222 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 25, 2017
Decision Date August 15, 2017
Days to Decision 202 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
115d slower than avg
Panel avg: 87d · This submission: 202d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LAF Device Classification - Class 2, Special Controls

Product Code LAF Gas Chromatography, Methamphetamine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3610
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Peers - LAF Gas Chromatography, Methamphetamine

All 39
Devices cleared under the same product code (LAF) and FDA review panel - the closest regulatory comparables to K170222.
SEFRIA Methamphetamine Oral Fluid Enzyme Immunoassay
K203647 · Immunalysis Corporation · Dec 2021
Psychemedics Homogeneous Enzyme Immunoassay for Amphetamines in Hair
K210212 · Psychemedics Corporation · Dec 2021
Lin-Zhi International, Inc. (LZI) Methamphetamine Enzyme Immunoassay for Pictus Analyzers
K201442 · Diatron Group · Jul 2020
Immunalysis Methamphetamine Urine Enzyme Immunoassay, Immunalysis Multi-Drug Calibrators
K153693 · Immunalysis Corporation · Mar 2016
Rapidfret Oral Fluid Assay for Methamphetamine, Rapidfret Oral Fluid Methamphetamine Calibrators, Rapidfret Oral Fluid Methamphetamine Controls
K142293 · Biophor Diagnostics, Inc. · Sep 2015
Healgen MDMA (Ecstacy) Test (Strip, Cassette, Cup, Dip Card), Healgen Phencyclidine Test (Strip, Cassette, Cup, Dip Card)
K150096 · Healgen Scientific, LLC · Mar 2015